An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Benznidazole

Chemical Namebenznidazole
Dosage FormTablet (oral; 12.5 mg, 100 mg)
Drug ClassAntiprotozoal
SystemBlood, Digestive, Cardiovascular, Nervous
CompanyChemo Research Sl
Approval Year2017

Indication

  • Benznidazole is indicated in pediatric patients 2 to 12 years of age for the treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi.
Last updated on 2/3/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Benznidazole (benznidazole) prescribing information.2017Exeltis
Document TitleYearSource
Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review.2020Journal of the Sao Paulo Institute of Tropical Medicine
Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)2020Cochrane Database of Systematic Reviews
Document TitleYearSource
Guidelines for the diagnosis and treatment of Chagas disease.2019WHO-Pan American Health Organization - WHO